Comparing the performance of gene expression assays in breast cancer

被引：2

作者：

Suthers, Graeme K. ^{[1
,2
]}

机构：

[1] Sonic Healthcare Australia, 14 Giffnock Ave, Macquarie Park, NSW 2113, Australia

[2] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia

来源：

INTERNATIONAL JOURNAL OF CANCER | 2019年 / 145卷 / 04期

关键词：

D O I：

10.1002/ijc.32290

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1162 / 1162

页数：1

共 6 条

[1] High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial [J].

Nielsen, Torsten O. ;

Jensen, Maj-Brit ;

Burugu, Samantha ;

Gao, Dongxia ;

Jorgensen, Charlotte L. Tykjaer ;

Balslev, Eva ;

Ejlertsen, Bent .

CLINICAL CANCER RESEARCH, 2017, 23 (04) :946-953

[2] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer [J].

Ohara, Ako Matsushita ;

Naoi, Yasuto ;

Shimazu, Kenzo ;

Kagara, Naofumi ;

Shimoda, Masafumi ;

Tanei, Tomonori ;

Miyake, Tomohiro ;

Kim, Seung Jin ;

Noguchi, Shinzaburo .

BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) :533-543

[3] Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial [J].

Sestak, Lvana ;

Buus, Richard ;

Cuzick, Jack ;

Dubsky, Peter ;

Monenwett, Ralf ;

Denkert, Carsten ;

Ferree, Sean ;

Sgroi, Dennis ;

Schnabel, Catherine ;

Baehner, Frederick L. ;

Mallon, Elizabeth ;

Dowsett, Mitch .

JAMA ONCOLOGY, 2018, 4 (04) :545-553

[4] Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer [J].

Sparano, J. A. ;

Gray, R. J. ;

Makower, D. F. ;

Pritchard, K. I. ;

Albain, K. S. ;

Hayes, D. F. ;

Geyer, C. E., Jr. ;

Dees, E. C. ;

Goetz, M. P. ;

Olson, J. A., Jr. ;

Lively, T. ;

Badve, S. S. ;

Saphner, T. J. ;

Wagner, L. I. ;

Whelan, T. J. ;

Ellis, M. J. ;

Paik, S. ;

Wood, W. C. ;

Ravdin, P. M. ;

Keane, M. M. ;

Moreno, H. L. Gomez ;

Reddy, P. S. ;

Goggins, T. F. ;

Mayer, I. A. ;

Brufsky, A. M. ;

Toppmeyer, D. L. ;

Kaklamani, V. G. ;

Berenberg, J. L. ;

Abrams, J. ;

Sledge, G. W., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02) :111-121

[5] Prospective Validation of a 21-Gene Expression Assay in Breast Cancer [J].

Sparano, J. A. ;

Gray, R. J. ;

Makower, D. F. ;

Pritchard, K. I. ;

Albain, K. S. ;

Hayes, D. F. ;

Geyer, C. E., Jr. ;

Dees, E. C. ;

Perez, E. A. ;

Olson, J. A., Jr. ;

Zujewski, J. A. ;

Lively, T. ;

Badve, S. S. ;

Saphner, T. J. ;

Wagner, L. I. ;

Whelan, T. J. ;

Ellis, M. J. ;

Paik, S. ;

Wood, W. C. ;

Ravdin, P. ;

Keane, M. M. ;

Gomez Moreno, H. L. ;

Reddy, P. S. ;

Goggins, T. F. ;

Mayer, I. A. ;

Brufsky, A. M. ;

Toppmeyer, D. L. ;

Kaklamani, V. G. ;

Atkins, J. N. ;

Berenberg, J. L. ;

Sledge, G. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (21) :2005-2014

[6] Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer [J].

Varga, Zsuzsanna ;

Sinn, Peter ;

Seidman, Andrew D. .

INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) :882-893

← 1 →